Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,038 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

NCT00136552

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
  • Hôpital Henri Mondor Créteil, France
  • Hôpital Saint Louis Paris, France
  • Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France
View Trial Details
Completed

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

NCT00344526

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Service des Maladies du Sang Lille, France
  • Service d'Hématologie et de Thérapie cellulaire Limoges, France
  • Service d'hématologie clinique Nantes, France
  • Service d'hématologie Clinique, Groupe Hospitalier Pitié-Salpétrière Paris, France
View Trial Details
Completed

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00491127

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain
View Trial Details
Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

NCT00039910

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +12 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site Loma Linda, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 38 locations
View Trial Details

Related conditions